최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기약학회지 = Yakhak hoeji, v.50 no.6, 2006년, pp.386 - 392
스리니바산 샨무감 (영남대학교 약학대학) , 정희용 (영남대학교 임상약학대학원) , 용철순 (영남대학교 약학대학) , 최한곤 (영남대학교 약학대학) , 김정애 (영남대학교 약학대학) , 유봉규 (영남대학교 약학대학)
Pramlintide, a synthetic analogue of human hormone amylin, is the first of a new class of amylinomimetic compounds. Present study was undertaken to compile and analyze the clinical trials of pramlintide, and thereby to facilitate the design of the bridging study for the earlier introduction of the d...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Havas, S. and Donner, T. : Tight control of type 1 diabetes: recommendations for patients. Am. Fam. Physician 74, 971 (2006)
Cramer, J. A. : A systematic review of adherence with medications for diabetes. Diabetes Care 27, 1218 (2004)
Stumvoll, M., Goldstein, B. J. and van Haeften, T. W. : Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333 (2005)
Vivian, E. M., Olarte, S. V. and Gutierrez, A. M. : Insulin strategies for type 2 diabetes mellitus. Ann. Pharmacother. 38, 1916 (2004)
식품의약품안전청 의약품안전국 : 외국임상자료의 평가, 가교자료 평가 및 가교시험 결정을 위한 가이드라인. 의약 65625-13552호(2000. 12. 29)
Kong, M. F., Stubbs, T. A., King, P., Macdonald, I. A., Lambourne, J. E., Blackshaw, P. E., Perkins, A. C. and Tattersall, R. B. : The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM. Diabetologia 41, 577 (1998)
Fineman, M., Weyer, C., Maggs, D. G., Strobel, S. and Kolterman, O. G. : The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus. Horm. Metab. Res. 34, 504 (2002)
Chapman, I., Parker, B., Doran, S., Feinle-Bisset, C., Wishart, J., Strobel, S., Wang, Y., Burns, C., Lush, C., Weyer, C. and Horowitz, M. : Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes. Diabetologia 48, 838 (2005)
Kong, M. F., King, P., Macdonald, I. A., Stubbs, T. A., Perkins, A. C., Blackshaw, P. E., Moyses, C. and Tattersall, R. B. : Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM. Diabetologia 40, 82 (1997)
Nyholm, B., Orskov, L., Hove, K. Y., Gravholt, C. H., Moller, N., Alberti, K. G., Moyses, C., Kolterman, O. and Schmitz, O. : The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus. Metabolism 48, 935 (1999)
Fineman, M. S., Koda, J. E., Shen, L. Z., Strobel, S. A., Maggs, D. G., Weyer, C. and Kolterman, O. G. : The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes. Metabolism 51, 636 (2002)
Symlin (pramlintide acetate) injection package insert. San Diego, CA: Amylin Pharmaceuticals, Inc. (2005)
McQueen J. Pramlintide acetate. Am. J. Health-Sys. Pharm. 62, 2363 (2005)
Amylin Pharmaceuticals, Inc. Study 137-125 (An open-label, randomized, four-period cross-over study in normal volunteers of the bioavailability of selected concentrations of pramlintide in two different formulations) filed in NDA 21-332 (2000)
Cada, D. J., Levien, T. and Baker, D. E. : Pramlintide acetate. Hospital Pharmacy 40, 599 (2005)
Amylin Pharmaceuticals, Inc. Study 137-119 (An open-lable, randomized, five-period cross-over study of the pharmacokinetics of subcutaneous pramlintide (AC137) versus placebo plus NPH and regular insulin mixed together and as separate single injections in patients with type 1 diabetes mellitus) filed in NDA 21-332 (2000)
Amylin Pharmaceuticals, Inc. Study 137-133 (A randomized, double-blind, placebo-controlled, single-dose, two-period cross-over study to evaluate the effect of pramlintide on the pharmacokinetics of ethinyl estradiol and norgestrel in healthy female subjects receiving the oral contraceptive, Lo/Ovral) filed in NDA 21-332 (2000)
Amylin Pharmaceuticals, Inc. Study 137-134 (A randomized, double-blind, placebo-controlled, single-dose, two-period cross-over study to determine the effect of pramlintide on the pharmacokinetics of ampicillin in healthy subjects) filed in NDA 21-332 (2000)
Fineman, M., Gottlieb, A., Bahner, A., Parker, J., Waite, G. and Kolterman, O. : Pramlintide therapy in addition to insulin in type 1 diabetes on metabolic control after 6 months. Diabetologia 42(suppl 1), Abstract 872 (1999)
Whitehouse, F., Kruger, D. F., Fineman, M., Shen, L., Ruggles, J. A., Maggs, D. G., Weyer, C. and Kolterman, O. G. : A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes. Diabetes Care 25, 724 (2002)
Ratner, R. E., Dickey, R., Fineman, M., Maggs, D. G., Shen, L., Strobel, S. A., Weyer, C. and Kolterman, O. G. : Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial. Diabet. Med. 21, 1204 (2004)
Gottlieb, A., Fineman, M., Bahner, A., Parker, J., Waite O. and Kolterman, O. : Pramlintide therapy in addition to insulin in type 2 diabetes on metabolic control after 6 months. Diabetologia 42(suppl 1), Abstract 873 (1999)
Ratner, R. E., Want, L. L., Fineman, M. S., Velte, M. J., Ruggles, J. A., Gottlieb, A., Weyer, C. and Kolterman, O. G. : Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes. Diabetes Technol. Ther. 4, 51 (2002).)
Hollander, P. A., Levy, P., Fineman, M. S., Maggs, D. G., Shen, L. Z., Strobel, S. A., Weyer, C. and Kolterman, O. G. : Pramlintide as an adjunct to insulin therapy improves longterm glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial. Diabetes Care 26, 784 (2003)
※ AI-Helper는 부적절한 답변을 할 수 있습니다.